Research
Doctoral program Clinical Pharmacy
​
The doctoral program Clinical Pharmacy is an interdisciplinary institution at the LMU Klinikum München. The doctoral projects deal with the topic of drug therapy safety in various patient groups. The foundation Patient & Clinical Pharmacy supports research projects and the annual symposia, among other things.
​
Influence of concomitant medication on side effects of checkpoint inhibitor therapy
​
As part of a translational research project, the hospital pharmacy and the Department of Medical II of the University Hospital Augsburg are investigating the influence of non-oncological concomitant medication on immune-related adverse events (irAE) and the response to therapy with checkpoint inhibitors. Data from cancer patients with solid tumours are analysed retrospectively. Prospectively, a structured drug history is also taken in order to be able to analyse potential influences on the immune profile and therapy response in a more targeted manner with a high level of data quality. The aim is to identify risk factors for irAE, improve treatment decisions and develop strategies for effective side effect management.
​
